Adcendo ApS Announces Extension of Series A Financing to EUR

Raises additional 16M EUR led by Dawn Biopharma, a platform controlled by KKR, with participation from existing investors.Funds will be used to further strengthen growing pipeline of first in

Related Keywords

Copenhagen , Køavn , Denmark , Iyona Rajkomar , Michael Pehl , Healthcare Strategic Growth Fund , Novo Holdings , Dawn Biopharma , Managing Partner , Adcendo Board , Ysios Capital , Gilde Healthcare , Pontifax Venture , Development Candidate Nomination , Chief Executive Officer , Board Director , Pontifax Venture Capital , Strategic Growth Fund , Ihr Portfolio ,